Cowen Aaron

Director, 10% OwnerBenitec Biopharma Inc. (BNTC) · full profile →Form 4 · filed Dec 29, 2025
Net Buying
Open-Market Buys
$1.9M
Open-Market Sells
$0
Net Open-Market Flow
$1.9M
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 29, 2025Buy(P)66K$13.44$884K9.7M
Dec 29, 2025Buy(P)12K$13.44$156K1.8M
Dec 26, 2025Buy(P)14K$13.10$188K9.6M
Dec 26, 2025Buy(P)3K$13.10$33K1.8M
Dec 23, 2025Buy(P)7K$12.85$95K1.8M
Dec 23, 2025Buy(P)43K$12.85$547K9.6M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899140-25-001479) within minutes of acceptance. Every field above traces to the original document. Verify it directly: